Iwamura H - Search Results

1

In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.

Iwamura H, Suzuki H, Ueda Y, Kaya T, Inaba T. Iwamura H, et al. J Pharmacol Exp Ther. 2001 Feb;296(2):420-5. J Pharmacol Exp Ther. 2001. PMID: 11160626

2

Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice.

Ueda Y, Miyagawa N, Matsui T, Kaya T, Iwamura H. Ueda Y, et al. Among authors: iwamura h. Eur J Pharmacol. 2005 Sep 27;520(1-3):164-71. doi: 10.1016/j.ejphar.2005.08.013. Eur J Pharmacol. 2005. PMID: 16153638

3

JTP-27536 [(+)-1,3-dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-[(R)-3-cyclo-hexyl-1-phenylpropyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylate monohydrate], a novel inhibitor of immunoglobulins and interleukin-5 with anti-inflammatory properties in mouse allergic dermatitis model.

Mimura T, Shinozaki Y, Kawasaki H, Iwamura H. Mimura T, et al. Among authors: iwamura h. J Pharmacol Exp Ther. 2005 Jul;314(1):293-301. doi: 10.1124/jpet.104.080846. Epub 2005 Apr 8. J Pharmacol Exp Ther. 2005. PMID: 15821026

4

Comparative study of glucocorticoids, cyclosporine A, and JTE-607 [(-)-Ethyl-N[3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzoyl]-L-phenylalaninate dihydrochloride] in a mouse septic shock model.

Iwamura H, Sato M, Wakitani K. Iwamura H, et al. J Pharmacol Exp Ther. 2004 Dec;311(3):1256-63. doi: 10.1124/jpet.104.072421. Epub 2004 Jul 27. J Pharmacol Exp Ther. 2004. PMID: 15280441

5

JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in mice.

Kakutani M, Takeuchi K, Waga I, Iwamura H, Wakitani K. Kakutani M, et al. Among authors: iwamura h. Inflamm Res. 1999 Aug;48(8):461-8. doi: 10.1007/s000110050487. Inflamm Res. 1999. PMID: 10493164

6

Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain.

Yamamoto W, Mikami T, Iwamura H. Yamamoto W, et al. Among authors: iwamura h. Eur J Pharmacol. 2008 Mar 31;583(1):56-61. doi: 10.1016/j.ejphar.2008.01.010. Epub 2008 Jan 26. Eur J Pharmacol. 2008. PMID: 18279850

7

Prophylactic effect of JTE-607 on LPS-induced acute lung injury in rats with CINC-1 inhibition.

Iwamura H, Inushima K, Takeuchi K, Kakutani M, Wakitani K. Iwamura H, et al. Inflamm Res. 2002 Mar;51(3):160-6. doi: 10.1007/pl00000288. Inflamm Res. 2002. PMID: 12005207

8

FF-10502, an Antimetabolite with Novel Activity on Dormant Cells, Is Superior to Gemcitabine for Targeting Pancreatic Cancer Cells.

Mima S, Kakinuma C, Higuchi T, Saeki K, Yamada T, Uematsu R, Ishino M, Kito N, Nishikawa H, Kuniyoshi H, Matsumoto T, Fujiwara H, Paradiso LJ, Shimada Y, Iwamura H. Mima S, et al. Among authors: iwamura h. J Pharmacol Exp Ther. 2018 Jul;366(1):125-135. doi: 10.1124/jpet.118.248740. Epub 2018 Apr 13. J Pharmacol Exp Ther. 2018. PMID: 29653962

9

JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues.

Wakitani K, Tazaki H, Matsushita M, Iwamura H. Wakitani K, et al. Among authors: iwamura h. Inflamm Res. 2000 Mar;49(3):117-22. doi: 10.1007/s000110050568. Inflamm Res. 2000. PMID: 10807499

10

T cell receptor beta chain gene rearrangements in leukemias with immature T cell phenotype.

Suzuki H, Ueda R, Obata Y, Seto M, Hirata R, Iwamura H, Ota K, Takahashi T. Suzuki H, et al. Among authors: iwamura h. Jpn J Cancer Res. 1986 Nov;77(11):1069-73. Jpn J Cancer Res. 1986. PMID: 3098715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters